FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) – The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S’s diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co’s Trulicity.

Leave a Reply

Your email address will not be published. Required fields are marked *